The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

A 57-year-old man who alleges that Cedars-Sinai Medical Center fired him as a mental health worker in 2023 for reasons related to his sleep apnea must take his claims before an arbitrator rather than ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

Proper side sleeping posture with a medium-firm mattress and aligned pillows prevents back soreness, reduces joint pain, and ...

Check out this year's top 5 pieces of sleep coverage that cover topics surveying the benefits of supplements, novel ...

The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...